
Development and commercialization of microfluidic technologies for cell therapy manufacturing, including integrated solutions for research and production.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Sebia
B
Development and marketing of specialized in vitro diagnostic solutions for various pathologies, including oncological, metabolic, genetic, autoimmune, and infectious diseases.
Capsum
A
End-to-end beauty contract manufacturing using microfluidic technology to create innovative and effective beauty products.
Aseptic Group
B
Specialist in sterile fluid transfer solutions in critical environments, focusing on single-use systems for bioproduction.
Initiatives identified among leaders
Réduction des empreintes carbone, eau et déchets via des processus optimisés
“Capsum réduit ses empreintes environnementales en ...” - CapsumAméliorer notre engagement social et sociétal
“Sebia considère l’ensemble de ses collaborateurs c...” - SebiaAméliorer notre engagement social et sociétal
“Sebia considère l’ensemble de ses collaborateurs c...” - Sebia62% of similar organizations communicate on CSR issues
+1081 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports